Company Profiles

driven by the PitchBook Platform

Aprecia Pharmaceuticals

Description

Developer and manufacturer of pharmaceuticals using 3D printing technology platform. The company provides various time release profiles, a orally dispersing wafers pairing a high dose ceiling with times, taste masking options that is suited for products requiring sub-milligram doses.

2003

Founded

PRIVATE

Status

51-200

Employees

Debt

Latest Deal Type

$20M

Latest Deal Amount

$157M

Total Amount Raised

Description

Developer and manufacturer of pharmaceuticals using 3D printing technology platform. The company provides various time release profiles, a orally dispersing wafers pairing a high dose ceiling with times, taste masking options that is suited for products requiring sub-milligram doses.

Website:

www.aprecia.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

2010 Cabot Boulevard West Suite F Langhorne, PA 19047United States +1 (513) 984-5000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aprecia Pharmaceuticals's full profile, request a free trial.

Aprecia Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aprecia Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Aprecia Pharmaceuticals Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alpha Capital PartnersPE/BuyoutMinority000 0000000 0000
Deerfield ManagementVenture CapitalMinority000 0000000 0000
Hercules CapitalGrowth/ExpansionMinority000 0000000 0000
JW Asset ManagementPE/BuyoutMinority000 0000000 0000
Alpha Capital Partners PE/Buyout
Deerfield Management Venture Capital
Hercules Capital Growth/Expansion
JW Asset Management PE/Buyout

Aprecia Pharmaceuticals Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Donald WetherholdChief Executive Officer
Donald MonkhousePresident
Michael RohlfsChief Financial Officer
Robert WillifordChief Operating Officer
Tom BradburyVice President of Development Engineering & Director of Process Automation
Donald Wetherhold Chief Executive Officer
Donald Monkhouse President
Michael Rohlfs Chief Financial Officer
Robert Williford Chief Operating Officer
Tom Bradbury Vice President of Development Engineering & Director of Process Automation

Aprecia Pharmaceuticals Board Members (2)

NameRepresentingRoleSinceContact
Info
E. Thomas AringtonSelfChairman000 0000
Lawrence GlassmannSelfBoard Member000 0000
E. Thomas Arington Chairman Self
Lawrence Glassmann Board Member Self
Request full access to PitchBook